Showing results (431-440 of 464) with videos related to

Sort By:
Pageof 47
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 1998
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's diseaseK Schiffman, C D Buckner, R Maziarz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantationM E Flowers, W Leisenring, K Beach, et al.
Bone Marrow Transplantation|April 21, 2009
Therapy with mycophenolate mofetil for refractory acute and chronic GVHDT Furlong, P Martin, M E D Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow TransplantationC S Chen, K Seidel, J O Armitage, et al.
Leukemia|May 21, 2010
Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remissionR B Walter, J M Pagel, T A Gooley, et al.
Blood|May 15, 1997
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trialH J Deeg, D Lin, W Leisenring, et al.
Blood|July 10, 1998
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phaseA J Morton, T Gooley, J A Hansen, et al.
Blood|April 1, 1983
Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?R Storb, R L Prentice, M Banaji, et al.
Blood|June 1, 1997
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell doseJ Sierra, B Storer, J A Hansen, et al.
Blood|August 1, 1996
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantationP J Martin, B J Nelson, F R Appelbaum, et al.
Pageof 47